​​​
  1. GlaxoSmithKline Pharma Q3 Net up 27% at Rs 128.67 crore

GlaxoSmithKline Pharma Q3 Net up 27% at Rs 128.67 crore

GlaxoSmithKline Pharmaceuticals today reported 27.45 per cent rise in its standalone net profit....

By: | New Delhi | Published: November 6, 2014 3:00 PM
GlaxoSmithKline Pharmaceuticals today reported 27.45 per cent rise in its standalone net profit (Reuters)

GlaxoSmithKline Pharmaceuticals today reported 27.45 per cent rise in its standalone net profit (Reuters)

GlaxoSmithKline Pharmaceuticals today reported 27.45 per cent rise in its standalone net profit at Rs 128.67 crore for the third quarter ended September.

The company had posted a net profit of Rs 100.95 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.

Standalone total income from operations also rose to Rs 746.76 crore for the quarter under consideration from Rs 626.65 crore for the same period year-ago, it added.

The company follows January-December financial year.

Established in 1924 in India, GlaxoSmithKline Pharmaceuticals’ product portfolio includes prescription medicines and vaccines.

The company’s prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Go to Top